M.D. Anderson Cancer Center: Vaginal Neoplasms trials

The registry lists 11 Vaginal Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 1 are open to participants now and 3 have results posted.

Phase 1 3Phase 2 2Phase 3 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic CancersRecruitingNCT03968406Phase 1
• Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE StudyTerminatedNCT04066894Phase 2Results posted
• DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated CancersTerminatedNCT03439085Phase 2Results posted
• Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic ChemoradiationCompletedNCT01536392Phase 3Results posted
• MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal CancerTerminatedNCT03634267Phase 1
• Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar CancersCompletedNCT03452332Phase 1
• Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and CancerTerminatedNCT02140021Not applicable
• Magnetic Resonance Imaging of Gynecologic Malignancies Involving the VaginaCompletedNCT01703195Not applicable
• Pelvic Fractures and Radiation Therapy for Cervical CancerStatus unknownNCT00800644
• Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic CancerActive, not recruitingNCT00791635
• Lymphoscintigraphy in Patients With Vaginal CancerCompletedNCT00528034Not applicable